By T.J. Coles
This is part 6 in our series. Parts 1 to 5 can be read here.
Since the US Food and Drug Administration was ordered to release Pfizer “vaccine” documents to the public in late 2021, hundreds of thousands of pages have provided invaluable insight to researchers.
In August, although slowing down as predicted, another object of note was revealed — this time in the form of a leaked online meeting of medical professionals expressing concerns over injection adverse events.
Their findings correlate with events we are seeing in the real-world data.
In January 2021, the Israeli government signed an extraordinary collaboration agreement in which Pfizer used Israel as “a sort of laboratory” (Chief Scientific Officer Philip Dormitzer), in which the vaccine candidate, which tellingly is described as a “product” in the agreement, was to be compared with natural immunity.
To quote the document: “the Parties agree that it would be highly beneficial from a public health perspective to track pandemic data in accordance with vaccination compliance in a Real-World context to evaluate whether herd immunity protection is observed during the Product vaccination program rollout.”
The entire indemnification paragraphs are redacted.
A critic of the project, Tehilla Shwartz Altshuler of the Israel Democracy Institute, describes it as “one of the … widest medical experiments on humans at the 21st century.”
In August, a Zoom meeting of Israeli health officials was leaked.
In the meeting, the health officials discuss long-term and serious adverse events from the injection:
They “identified new [neurological] side effects not listed in the consumers’ leaflet, such as dizziness, tinnitus, hypoesthesia, [and] paraesthesia” (i.e., numbness and localised paralysis).
In addition, the duration of adverse events was longer than those reported in the official Pfizer data.
The leaflet said that side effects would typically last less than a week.
But in half of cases recorded by the Israeli doctors, duration was six months.
In terms of neurological events, 65 percent of sufferers experienced symptoms lasting longer than one month. Back pain, including in children, was another unexpected adverse event.
The leak comes at a time when European countries are reporting unexplained rises in excess mortality (i.e., death rates higher than average).
Pfizer told us that the injection was “safe and effective.”
It is easy to say that something is “safe and effective” when safety and efficacy are not defined: as indeed they were not in the clinical trials.
But over the last couple of years, data have emerged suggesting that the injection is neither effective (i.e., waning immunity, does not prevent infection) nor safe.
How can a vaccine candidate be safe when the normal decade of development, including pharmacovigilance, was shrunk to a few months, in the case of the rushed jab?
According to data drawn from the UK Office for Health Improvement and Disparities, non-heatwave related summer deaths this year were 3,665 above the average (28k deaths in total), of which COVID contributed to 909.
This means that 2,756 more people died in the summer of 2022 than expected compared to previous years.
Main causes were: Ischaemic heart disease (>1.9k excess), heart failure (>1.9k excess), diabetes (>1.7k excess), diseases of the urinary system (882 excess), cerebrovascular diseases (679 excess), acute respiratory infections (430 excess), chronic lower respiratory (368 excess), and cancer (210 excess).
Cancer can be explained by delayed treatments due to health service backlogs.
Diabetes can be explained by people eating and drinking more during lockdown.
But what about the staggeringly high increase in heart disease and failure?
Some deaths can be attributed to long COVID, delayed hospital treatment, and lockdown stress (e.g., lack of exercise, anxiety, overeating, etc.), but the major change between 2022 and previous years is that most British people have been double, and some even triple, jabbed.
It is interesting to note urinary infection as one of the causes of excess mortality because medical journals have been reporting cases of post-injection kidney disease.
Interstitial nephritis is a condition in which the kidney’s tubules are inflamed. The condition reduces the organ’s ability to filter waste and fluid.
Czerlau and the team found that five of their patients—they don’t reveal the sample size, which is odd—experienced acute interstitial nephritis after injection.
One of the patients had existing nephropathy (kidney deterioration) and four did not.
High serum creatinine (SC) levels can suggest that kidneys are in distress. The SC values of Patient 1’s kidneys prior to injection were 76.5 μmol/L. After injection, they had jumped to 355 μmol/L. Patient 2’s values could not be compared due to lack of prior data.
Patient 3 already had nephropathy. Their values ballooned from 167 μmol/L to 355. Patients’ 4 and 5 increased from 76 and 49 to 86 and 100, respectively.
A biopsy showed no evidence of disease in Patient 1, but Patient 2 had developed focal segmental glomerulosclerosis (FSGS): a disease that inhibits the kidney’s ability to filter waste.
Podocytes are cells that encase the capillaries of the glomerulus. Patient 3, who already had FSGS, was found to have contradicted this condition.
Mesangial IgA deposits indicate nephropathy. Patients 4 and 5 had significant levels.
The patients were successfully treated with cortisone though their serum creatinine tests revealed higher values than before the jab.
In addition to kidneys, liver disease has been noted, post-jab. This, unfortunately, is normal for new medical products. Hepatotoxicity is toxic liver disease; also a form of hepatitis.
One study notes that, in general: “Drug-induced hepatotoxicity leads to nearly 10% of all cases of acute hepatitis and more than 50% cases of liver failure.” (The study then goes on to trumpet the jab.)
Given the high prevalence of new and quickly withdrawn drugs causing liver damage, it is important to examine the Pfizer and other injections.
As noted in our previous Pfizer Papers articles, FOIA-released documents prove that the company was negligent in following up on patient health surveillance, including deaths, after injection.
Referring to all companies’ COVID-related injectable products, Hoo and the team note:
“These vaccines caused rare side effects not known during clinical trials” (emphasis added).
COVID increases the risk of acute liver injury. But what about the jab?
A recent summary in Nature tells us that there is no risk of acute liver injury after injection. But the original study, which also denies causation, says that 828 people per 100,000 double-dosed with Pfizer-BioNTech within 56 days developed diagnosed acute liver injury.
But what about undiagnosed injury?
It is normal scientific practice to compare cohorts: an injection-damaged group to a non-damaged group, for example. Yet, multiple papers suggesting injury omit comparative data.
Roy and the team studied post-jab immune-mediated liver injury in 23 patients acquired from a large dataset, though we don’t know compared to who or how many.
Lymphoplasmacytic infiltrate can be a kind of rare, slow-acting cancer.
Roy et al. found that this was the most common immune-mediated liver injury in the jabbed patients. Hepatocytes constitute most of the liver’s known mass.
Interface hepatitis is the death of those cells at certain sites. The researchers also found that interface hepatitis was a common post-injection phenomenon.
The Israeli health officials’ leaked Zoom call provides invaluable insight into long-term side-effects that are of no interest to Pfizer.
Against the backdrop of unexplained excess mortality, there is also a mounting body of peer-reviewed evidence revealing long-term acute physical and neurological damage.
Dr. T.J. Coles is the author of several books, including — The War on You.
Check out T.J’s Amazon page by clicking here.
View more TOTT content from Coles here.
For more hard-hitting news, follow us:
Facebook — Facebook.com/TOTTNews
YouTube — YouTube.com/TOTTNews
Instagram — Instagram.com/TOTTNews
Twitter — Twitter.com/EthanTOTT